← Leaderboards
Kimberly Stigler
Indiana University Indianapolis
$920,418
Attributed
$920,418
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $184.6K · FY2008–12$200K$150K$100K$50K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$920,418 · 1
By mechanism
K23$920,418 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Eric M. Meslin$2,035,700
- Brian E. Dixon$5,147,904
- Thomas D. Hurley$11,294,425
- Andrew D Gavrin$966,763
- Ann Carol Kimble-Hill$1,085,483
Others in their field
Top investigators on “Impairment”
- Michael W Weiner · Northern California Institute Res &Educ$150,110,797
- Paul S. Aisen · Cognition Therapeutics, Inc.$147,845,108
- Randall J Bateman · Washington University$142,003,126
- Reisa A. Sperling · Banner Health$119,578,342
- Carol Nesel · Westat$116,355,411
- David A Bennett · Rush University Medical Center$95,936,887
Research focus
ImpairmentAdverse EffectsAcuteAreaAripiprazoleAsperger SyndromeAggressive BehaviorAdolescentBehaviorBiometryCareerCaringChildClinical ResearchAutistic DisorderCostAwarenessDiagnosticDoctor Of MedicineDouble-Blind MethodDouble-Blind Placebo Controlled TrialEffectivenessElectrocardiogramIncidence
Grant awards (5)
Pharmacotherapy of Pervasive Developmental Disorders$182,830
K23 · FY2012 · MH · contact PI
Pharmacotherapy of Pervasive Developmental Disorders$184,540
K23 · FY2011 · MH · contact PI
Pharmacotherapy of Pervasive Developmental Disorders$184,587
K23 · FY2010 · MH · contact PI
Pharmacotherapy of Pervasive Developmental Disorders$184,259
K23 · FY2009 · MH · contact PI
Pharmacotherapy of Pervasive Developmental Disorders$184,202
K23 · FY2008 · MH · contact PI